SOL S.P.A.        EO 0,52
SOL S.P.A. EO 0,52
Aktie · IT0001206769 · 915322 (XMIL)
Übersicht
Kein Kurs
Schlusskurs XMIL 09.12.2025: 49,25 EUR
12.12.2025 16:04
Aktuelle Kurse von SOL S.P.A. EO 0,52
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XFRA: Frankfurt
Frankfurt
QOL.F
EUR
12.12.2025 16:04
48,85 EUR
1,00 EUR
+2,09 %
XDQU: Quotrix
Quotrix
SSAAEO69.DUSD
EUR
12.12.2025 06:27
49,05 EUR
1,20 EUR
+2,51 %
XDUS: Düsseldorf
Düsseldorf
SSAAEO69.DUSB
EUR
11.12.2025 18:31
48,60 EUR
0,20 EUR
+0,41 %
XMIL: BORSA ITALIANA S.P.A.
BORSA ITALIANA S.P.A.
SOL.MI
EUR
09.12.2025 08:18
49,25 EUR
0,25 EUR
+0,51 %
Free Float & Liquidität
Free Float 36,98 %
Shares Float 33,54 M
Ausstehende Aktien 90,7 M
Investierte Fonds

Folgende Fonds haben in SOL S.P.A. EO 0,52 investiert:

Fonds
iShares FTSE Italia Mid-Small Cap UCITS ETF EUR (Acc)
Vol. in Mio
472,87
Anteil (%)
1,24 %
Firmenprofil zu SOL S.P.A. EO 0,52 Aktie
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home medical assistance and related medical equipment in Italy and internationally. The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use. It also provides home oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids. In addition, it provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services. Further, it designs, constructs, and manages bio banks; distribution of medical and technical gases; produces and sells hydroelectric power; offers pre-and post-natal diagnostic screening services; produces and sells diagnostic systems; researches, develops, and markets products for research, diagnosis and clinical application in the hospital, environmental, veterinary and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples. Its products are used in the chemical, electronics, steel, metal, and food industries, as well as in environmental protection, and research and healthcare sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.
Erhalte tagesaktuelle Insights vom finAgent über SOL S.P.A. EO 0,52

Unternehmensdaten

Name SOL S.P.A. EO 0,52
Firma SOL S.p.A.
Website https://www.solgroup.com
Heimatbörse XMIL BORSA ITALIANA S.P.A.
WKN 915322
ISIN IT0001206769
Wertpapierart Aktie
Sektor Basic Materials
Branche Chemicals
CEO Engineer Aldo Fumagalli Romario
Marktkapitalisierung 4 Mrd.
Land Italien
Währung EUR
Mitarbeiter 7,2 T
Adresse Via Borgazzi, 27, 20900 Monza
IPO Datum 1998-07-17

Ticker Symbole

Name Symbol
BORSA ITALIANA S.P.A. SOL.MI
Düsseldorf SSAAEO69.DUSB
Frankfurt QOL.F
Quotrix SSAAEO69.DUSD
Weitere Aktien
Investoren, die SOL S.P.A. EO 0,52 halten, haben auch folgende Aktien im Depot:
Eezy Oyj
Eezy Oyj Aktie
UBS (LUX) BOND FUND - CONVERT EUROPE (EUR) I-A1-DIST
UBS (LUX) BOND FUND - CONVERT EUROPE (EUR) I-A1-DIST ETF
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025